Welcome to our dedicated page for ENSYSCE BIOSCIENCE WTS news (Ticker: enscw), a resource for investors and traders seeking the latest updates and insights on ENSYSCE BIOSCIENCE WTS stock.
Ensysce Biosciences, Inc. (NASDAQ:ENSCW) is a clinical-stage company specializing in developing safer prescription drugs utilizing transformative chemistry to enhance drug safety. The company's TAAP(TM) prodrug of oxycodone, PF614, has shown positive results in clinical studies and provides a longer half-life, benefiting severe pain treatment. Ensysce's technology platforms, TAAP(TM) and MPAR(R), aim to provide tamper-proof treatment options to minimize drug abuse and overdose risks, with a focus on reducing medication abuse deaths.
FAQ
What is the current stock price of ENSYSCE BIOSCIENCE WTS (enscw)?
What is Ensysce Biosciences known for?
What is the key product of Ensysce Biosciences?
How does Ensysce Biosciences aim to minimize drug abuse and overdose risks?
What sets Ensysce Biosciences apart?
What recent achievement has Ensysce Biosciences made?
